Keizo Anzai

3.9k total citations · 1 hit paper
117 papers, 2.6k citations indexed

About

Keizo Anzai is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Keizo Anzai has authored 117 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 31 papers in Hepatology and 25 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Keizo Anzai's work include Liver Disease Diagnosis and Treatment (42 papers), Hepatitis C virus research (18 papers) and Diabetes and associated disorders (15 papers). Keizo Anzai is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Hepatitis C virus research (18 papers) and Diabetes and associated disorders (15 papers). Keizo Anzai collaborates with scholars based in Japan, United States and Australia. Keizo Anzai's co-authors include Hirokazu Takahashi, Yuichiro Eguchi, Yoichiro Kitajima, Takumi Kawaguchi, Iwata Ozaki, Dan Nakano, Shinobu Yoshinaga, Takuji Torimura, Sakura Yamamura and Tsubasa Tsutsumi and has published in prestigious journals such as JAMA, Nature Communications and PLoS ONE.

In The Last Decade

Keizo Anzai

110 papers receiving 2.6k citations

Hit Papers

MAFLD identifies patients with significant hepatic fibros... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keizo Anzai Japan 28 1.4k 659 624 557 511 117 2.6k
Bunzo Matsuura Japan 34 2.0k 1.5× 823 1.2× 1.3k 2.0× 670 1.2× 445 0.9× 211 3.9k
Samar H. Ibrahim United States 25 1.7k 1.3× 438 0.7× 811 1.3× 252 0.5× 1.1k 2.1× 54 3.0k
Neşe İmeryüz Türkiye 27 988 0.7× 371 0.6× 302 0.5× 286 0.5× 369 0.7× 78 1.9k
Venanzio Valenza Italy 17 1.2k 0.9× 406 0.6× 323 0.5× 614 1.1× 651 1.3× 48 2.0k
Stephen Hodges United Kingdom 29 1.2k 0.9× 272 0.4× 1.2k 1.9× 263 0.5× 543 1.1× 47 3.0k
Ilaria Barchetta Italy 25 982 0.7× 524 0.8× 182 0.3× 515 0.9× 333 0.7× 72 2.1k
Noriyuki Takeda Japan 24 1.6k 1.2× 1.1k 1.7× 521 0.8× 343 0.6× 382 0.7× 77 3.0k
Yongde Peng China 30 933 0.7× 935 1.4× 137 0.2× 435 0.8× 1.0k 2.0× 117 3.1k
Shriram Jakate United States 28 962 0.7× 206 0.3× 371 0.6× 408 0.7× 812 1.6× 98 3.5k
Kemal Dağalp Türkiye 18 898 0.7× 522 0.8× 183 0.3× 224 0.4× 360 0.7× 46 1.7k

Countries citing papers authored by Keizo Anzai

Since Specialization
Citations

This map shows the geographic impact of Keizo Anzai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keizo Anzai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keizo Anzai more than expected).

Fields of papers citing papers by Keizo Anzai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keizo Anzai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keizo Anzai. The network helps show where Keizo Anzai may publish in the future.

Co-authorship network of co-authors of Keizo Anzai

This figure shows the co-authorship network connecting the top 25 collaborators of Keizo Anzai. A scholar is included among the top collaborators of Keizo Anzai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keizo Anzai. Keizo Anzai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagafuchi, Seiho, Satoru Akazawa, Norio Abiru, et al.. (2024). TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes. Nature Communications. 15(1). 1337–1337. 10 indexed citations
2.
Sakamoto, Yoshiko, Kaori Inoue, Hiroki Takayanagi, et al.. (2024). FIB-4 Index and Liver Stiffness Measurement are Potential Predictors of Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Atherosclerosis and Thrombosis. 32(2). 239–252. 1 indexed citations
3.
Inoue, Akira, et al.. (2023). A case of repeated severe hypoglycemia caused by accidental ingestion of sulfonylurea in an elderly patient. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 60(3). 294–300.
4.
Takahashi, Hirokazu, et al.. (2021). Tailored notification encouraging examinees with abnormal glucose levels in health checkups to seek medical care. Diabetology International. 13(1). 262–271.
5.
Ozaki, Iwata, Yuzo Murata, Jing Guo, et al.. (2020). Degradation of the Tumor Suppressor PDCD4 Is Impaired by the Suppression of p62/SQSTM1 and Autophagy. Cells. 9(1). 218–218. 13 indexed citations
6.
Yamamura, Sakura, Takumi Kawaguchi, Dan Nakano, et al.. (2019). Profiles of advanced hepatic fibrosis evaluated by FIB‐4 index and shear wave elastography in health checkup examinees. Hepatology Research. 50(2). 199–213. 30 indexed citations
7.
Kakiuchi, Toshihiko, Muneaki Matsuo, Hiroyoshi Endo, et al.. (2019). A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. Journal of Gastroenterology. 54(8). 699–707. 40 indexed citations
8.
Yamasaki, Satoko, Yasuhisa Sakata, Hisako Yoshida, et al.. (2018). Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis. Digestion. 100(4). 247–253. 4 indexed citations
9.
Hua, Ning, Kazuhiro Takahashi, Yoichiro Kitajima, et al.. (2017). Influence of muscle fiber type composition on early fat accumulation under high-fat diet challenge. PLoS ONE. 12(8). e0182430–e0182430. 24 indexed citations
10.
Aikata, Hiroshi, Kazuaki Chayama, Kento Imajo, et al.. (2014). Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients Takashi NakaharaHideyuki HyogoMasato YonedaYoshio SumidaYuichiro EguchiHideki Fujii • Masafumi OnoTakumi KawaguchiKento ImajoHiroshi AikataSaiyu TanakaKazuyuki Kanemasa • Kazuma FujimotoKeizo AnzaiToshiji SaibaraMichio SataAtushi NakajimaYoshito Itoh • Kazuaki ChayamaTakeshi OkanoueJapan Study Group of Nonalcoholic Fatty Liver …. 3 indexed citations
11.
Kawaguchi, Yasunori, Satoshi Oeda, Toshihiko Mizuta, et al.. (2013). Current management practices for HBs antigen or anti-HCV antibody positive individuals in non-hepatology departments at a university hospital. Kanzo. 54(5). 307–316. 14 indexed citations
12.
Nakahara, Takashi, Hideyuki Hyogo, Masato Yoneda, et al.. (2013). Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. Journal of Gastroenterology. 49(11). 1477–1484. 119 indexed citations
13.
Anzai, Keizo, Yuko Akehi, Ryoko Yoshida, et al.. (2011). Criteria for Early Identification of Aceruloplasminemia. Internal Medicine. 50(13). 1415–1418. 34 indexed citations
14.
Kawaguchi, Yasunori, Toshihiko Mizuta, Takuya Kuwashiro, et al.. (2010). Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C. Journal of Gastroenterology. 46(4). 529–535. 12 indexed citations
15.
Anzai, Keizo, Koji Fukagawa, Ryuichi Iwakiri, et al.. (2009). Increased Lipid Absorption and Transport in the Small Intestine of Zucker Obese Rats. Journal of Clinical Biochemistry and Nutrition. 45(1). 82–85. 7 indexed citations
16.
Katsuta, Hitoshi, Keizo Anzai, Tarou Irié, et al.. (2005). cDNA microarray analysis after laser microdissection in proliferating islets of partially pancreatectomized mice. Medical Molecular Morphology. 38(1). 30–35. 7 indexed citations
17.
Kato, Kei, et al.. (2001). Elevated serum-soluble fas ligand in Histiocytic necrotizing lymphadenitis. International Journal of Hematology. 73(1). 84–86. 19 indexed citations
18.
Takata, Tohru, et al.. (1998). Analysis of the Expression of CagA and VacA and the Vacuolating Activity in 167 Isolates From Patients With Either Peptic Ulcers or Non-Ulcer Dyspepsia. The American Journal of Gastroenterology. 93(1). 30–34. 33 indexed citations
19.
Nagafuchi, Seiho, Hiromi Ishibashi, Keizo Anzai, et al.. (1994). Budd-Chiari syndrome and Epstein-Barr virus (EBV) associated plasmacytoma in a patient with chronic active EBV infection. Journal of Molecular Medicine. 72(11). 883–6. 4 indexed citations
20.
Nakano, Shuji, Kenji Mitsugi, Keizo Anzai, et al.. (1992). In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line. Cancer Chemotherapy and Pharmacology. 29(4). 273–276. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026